122 related articles for article (PubMed ID: 11976603)
41. A novel method for automatic determination of different stages of multiple sclerosis lesions in brain MR FLAIR images.
Khayati R; Vafadust M; Towhidkhah F; Nabavi SM
Comput Med Imaging Graph; 2008 Mar; 32(2):124-33. PubMed ID: 18055174
[TBL] [Abstract][Full Text] [Related]
42. Cross-relaxation imaging reveals detailed anatomy of white matter fiber tracts in the human brain.
Yarnykh VL; Yuan C
Neuroimage; 2004 Sep; 23(1):409-24. PubMed ID: 15325389
[TBL] [Abstract][Full Text] [Related]
43. Diffusion tensor MRI in multiple sclerosis.
Rovaris M; Filippi M
J Neuroimaging; 2007 Apr; 17 Suppl 1():27S-30S. PubMed ID: 17425731
[TBL] [Abstract][Full Text] [Related]
44. [Medical image automatic adjusting window and segmentation].
Zhou Z; Chen S; Tao D; Chen X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):331-4. PubMed ID: 15884547
[TBL] [Abstract][Full Text] [Related]
45. Pattern recognition system for the discrimination of multiple sclerosis from cerebral microangiopathy lesions based on texture analysis of magnetic resonance images.
Theocharakis P; Glotsos D; Kalatzis I; Kostopoulos S; Georgiadis P; Sifaki K; Tsakouridou K; Malamas M; Delibasis G; Cavouras D; Nikiforidis G
Magn Reson Imaging; 2009 Apr; 27(3):417-22. PubMed ID: 18786795
[TBL] [Abstract][Full Text] [Related]
46. Focal thinning of the cerebral cortex in multiple sclerosis.
Sailer M; Fischl B; Salat D; Tempelmann C; Schönfeld MA; Busa E; Bodammer N; Heinze HJ; Dale A
Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
[TBL] [Abstract][Full Text] [Related]
47. Cell-oriented analysis in vivo using diffusion tensor imaging for normal-appearing brain tissue in multiple sclerosis.
Terajima K; Matsuzawa H; Tanaka K; Nishizawa M; Nakada T
Neuroimage; 2007 Oct; 37(4):1278-85. PubMed ID: 17689265
[TBL] [Abstract][Full Text] [Related]
48. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
[TBL] [Abstract][Full Text] [Related]
49. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
[TBL] [Abstract][Full Text] [Related]
50. Quantitative MRI for the assessment of bone structure and function.
Wehrli FW; Song HK; Saha PK; Wright AC
NMR Biomed; 2006 Nov; 19(7):731-64. PubMed ID: 17075953
[TBL] [Abstract][Full Text] [Related]
51. Commentary: the past, present and future of imaging in multiple sclerosis.
Kam A
J Clin Neurosci; 2010 Nov; 17(11):1482. PubMed ID: 20727768
[No Abstract] [Full Text] [Related]
52. [What can be expected from brain MRI in early-stage multiple sclerosis?].
Grimaud J; Hermier M; Rovaris M
Rev Neurol (Paris); 2001 Jan; 157(1):13-9. PubMed ID: 11240544
[No Abstract] [Full Text] [Related]
53. [Processing of general image surfaces using a multi-framing method].
Bödi R; Kaulich TW
Biomed Tech (Berl); 1989; 34 Suppl():30-1. PubMed ID: 2819196
[No Abstract] [Full Text] [Related]
54. [Magnetic resonance and multiple sclerosis].
Prieto JM; Dapena D; Pardo J; Noya M
Neurologia; 1992 Feb; 7(2):83-4. PubMed ID: 1610607
[No Abstract] [Full Text] [Related]
55. Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes.
Rudick RA; Fisher E
Mult Scler; 2013 Jul; 19(8):1003-4. PubMed ID: 23818018
[No Abstract] [Full Text] [Related]
56. Correction for variations in MRI scanner sensitivity in brain studies with histogram matching.
Wang L; Lai HM; Barker GJ; Miller DH; Tofts PS
Magn Reson Med; 1998 Feb; 39(2):322-7. PubMed ID: 9469718
[TBL] [Abstract][Full Text] [Related]
57. Visual fuzzy cluster analysis of MR images.
Young SW; Ballerio C; Carrol CL
AJR Am J Roentgenol; 1989 Jan; 152(1):19-25. PubMed ID: 2642361
[No Abstract] [Full Text] [Related]
58. Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
Eloyan A; Shou H; Shinohara RT; Sweeney EM; Nebel MB; Cuzzocreo JL; Calabresi PA; Reich DS; Lindquist MA; Crainiceanu CM
PLoS One; 2014; 9(9):e107263. PubMed ID: 25233361
[TBL] [Abstract][Full Text] [Related]
59. Objective Evaluation of Multiple Sclerosis Lesion Segmentation using a Data Management and Processing Infrastructure.
Commowick O; Istace A; Kain M; Laurent B; Leray F; Simon M; Pop SC; Girard P; Améli R; Ferré JC; Kerbrat A; Tourdias T; Cervenansky F; Glatard T; Beaumont J; Doyle S; Forbes F; Knight J; Khademi A; Mahbod A; Wang C; McKinley R; Wagner F; Muschelli J; Sweeney E; Roura E; Lladó X; Santos MM; Santos WP; Silva-Filho AG; Tomas-Fernandez X; Urien H; Bloch I; Valverde S; Cabezas M; Vera-Olmos FJ; Malpica N; Guttmann C; Vukusic S; Edan G; Dojat M; Styner M; Warfield SK; Cotton F; Barillot C
Sci Rep; 2018 Sep; 8(1):13650. PubMed ID: 30209345
[TBL] [Abstract][Full Text] [Related]
60. An additional monogenic disorder that masquerades as multiple sclerosis.
Vahedi K; Tournier-Lasserve E; Vahedi K; Chabriat H; Bousser MG
Am J Med Genet; 1996 Nov; 65(4):357-8. PubMed ID: 8923950
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
